We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

251 hedge funds and large institutions have $8.13B invested in Vaxcyte in 2024 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 102 increasing their positions, 77 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 18

37% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $12.2M

32% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 77

25% more capital invested

Capital invested by funds: $6.51B → $8.13B (+$1.63B)

13% more funds holding

Funds holding: 223 → 251 (+28)

0.97% more ownership

Funds ownership: 108.91% → 109.87% (+0.97%)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

Holders
251
Holders Change
+28
Holders Change %
+12.56%
% of All Funds
3.62%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
48
Increased
102
Reduced
77
Closed
18
Calls
$16.7M
Puts
$12.2M
Net Calls
+$4.53M
Net Calls Change
-$2.42M

Top Buyers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$160M
2
DGM
Darwin Global Management
Jersey
+$150M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$142M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$89M
5
PBA
Paradigm Biocapital Advisors
New York
+$85.9M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$40.5M
2
Millennium Management
Millennium Management
New York
-$33.5M
3
VPC
Vestal Point Capital
New York
-$33M
4
GPP
Great Point Partners
Connecticut
-$22.6M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$19.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
51
Tang Capital Management
California
$20.5M – – –
EC
52
EcoR1 Capital
California
$20.5M +$20.8M +300,000 New
Bank of America
53
Bank of America
North Carolina
$19.5M +$7.74M +111,725 +64%
APM
54
Avidity Partners Management
Texas
$19.4M -$19.8M -286,137 -50%
TD Asset Management
55
TD Asset Management
Ontario, Canada
$19.2M +$7.91M +114,252 +68%
Victory Capital Management
56
Victory Capital Management
Texas
$19.2M -$6.82M -98,532 -26%
CM
57
Cercano Management
Washington
$18.6M +$18.8M +272,151 New
Amundi
58
Amundi
France
$18.3M -$1.9M -27,431 -8%
FTM
59
First Turn Management
California
$17.8M -$6.73M -97,247 -27%
SCM
60
Soleus Capital Management
Connecticut
$14.2M -$14.4M -207,700 -50%
Millennium Management
61
Millennium Management
New York
$14.1M -$33.5M -484,450 -70%
EP
62
Eversept Partners
New York
$13.5M -$2.53M -36,508 -16%
Aberdeen Group
63
Aberdeen Group
United Kingdom
$13.3M – – –
VOYA Investment Management
64
VOYA Investment Management
Georgia
$13M +$401K +5,791 +3%
Comerica Bank
65
Comerica Bank
Texas
$12.8M +$17K +246 +0.1%
SVCM
66
Saturn V Capital Management
Texas
$12.6M +$12.8M +185,175 New
Swiss National Bank
67
Swiss National Bank
Switzerland
$12.2M +$2.08M +30,100 +20%
UBS Group
68
UBS Group
Switzerland
$12M +$696K +10,044 +6%
SBH
69
Segall Bryant & Hamill
Illinois
$10.8M -$156K -2,260 -1%
California Public Employees Retirement System
70
California Public Employees Retirement System
California
$10.7M +$4.08M +58,851 +60%
PHP
71
Parkman Healthcare Partners
Connecticut
$10.2M -$8.15M -117,638 -44%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$10.1M +$1.23M +17,743 +14%
Citigroup
73
Citigroup
New York
$9.9M +$4.57M +65,955 +84%
Deutsche Bank
74
Deutsche Bank
Germany
$9.3M -$1.12M -16,110 -11%
Barclays
75
Barclays
United Kingdom
$8.83M -$5.02M -72,446 -36%
1 2
3
4 5

PCVX Hedge Fund Activity: Q1 2024 in Review

251 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q1 2024, worth a combined $8.13B — up 25% from $6.51B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new PCVX positions and 18 closed out — a net gain of 30 holders — while 102 added to existing stakes and 77 trimmed.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $160M. The largest seller was Morgan Stanley, cutting an estimated $40.5M.

  • 251 institutional investors held Vaxcyte (PCVX) as of Q1 2024, up from 223 in Q4 2023.
  • Funds reported $8.13B of Vaxcyte stock for Q1 2024, up 25% quarter-over-quarter.
  • 48 funds opened new Vaxcyte positions in Q1 2024 and 18 closed out, a net change of +30 holders.
  • The largest Vaxcyte buyer in Q1 2024 was T. Rowe Price Investment Management, an estimated $160M added.
  • The largest Vaxcyte seller in Q1 2024 was Morgan Stanley, an estimated $40.5M sold.

Based on aggregated 13F filings for Q1 2024.